布地奈德吸入治疗小儿急性感染性喉炎的疗效观察  

Therapeutic Effect of Budesonide Inhalation on Acute Infectious Laryngitis in Children

作　　者：赵立平[1] 陈碧芬[1] 

机构地区：[1]解放军第174医院儿科,福建厦门361003

出　　处：《临床军医杂志》2006年第1期29-30,共2页Clinical Journal of Medical Officers

摘　　要：目的观察布地奈德(BUD)吸入对小儿急性喉炎、喉气管支气管炎的疗效。方法将60例患儿随机分为两组,治疗组30例,给予雾化吸入BUD混悬液;对照组30例,给予地塞米松(DXM)雾化吸入。观察用药后患儿症状体征改善情况及其消失天数。结果治疗组经治疗后症状、体征改善及消失天数等各项指标,均明显优于对照组(P<0.01)。结论急性喉炎、急性喉气管支气管炎患儿在抗感染等常规治疗的同时,加用BUD吸入治疗,对改善症状体征、缩短病程,明显优于DXM吸入治疗,且疗效显著。Objective To observe the therapeutic effect of budesonide （BUD） inhalation on acute infectious laryngitis and laryngotracheobronchitis in children. Methods Child patients （n = 60） were divided into two groups, i.e. treatment group （n = 30） and control group （n = 30） at random, which were treated with atomizing inhalation respectively with BUD suspension and dexamethasone. The improvements in the symptoms and the signs, as well as the healing duration, were observed. Results More effective outcome was gained in the treatment group than in the control group （P 〈 0.01 ）. Conclusion In addition to routine treatment such as anti- infection, BUD atomizing inhalation is more effective on acute infectious＇laryngitis and laryngotracheobronchitis than dexamethasone on the aspect of improvements in symptom; sign and healing duration in children.

关 键 词：急性喉炎 喉气管支气管炎 布地奈德 吸入治疗 

分 类 号：R767.11[医药卫生—耳鼻咽喉科]